2013
DOI: 10.1016/j.pbb.2013.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 47 publications
1
16
0
Order By: Relevance
“…Metabolites in Table 2 were input into Metaboanalyst and the metabolic networks were depicted (Figure 4B ). The result showed that paclitaxel primarily disturbed the LA metabolism (impact 1.0) and glycerophospholipid metabolism (impact 0.18), which was in accord with published literatures (Patwardhan et al, 2010 ; Wang et al, 2013 ; Sisignano et al, 2016 ). And LA metabolism was considered as a preferred target pathway of paclitaxel due to its significant impact score.…”
Section: Resultssupporting
confidence: 89%
“…Metabolites in Table 2 were input into Metaboanalyst and the metabolic networks were depicted (Figure 4B ). The result showed that paclitaxel primarily disturbed the LA metabolism (impact 1.0) and glycerophospholipid metabolism (impact 0.18), which was in accord with published literatures (Patwardhan et al, 2010 ; Wang et al, 2013 ; Sisignano et al, 2016 ). And LA metabolism was considered as a preferred target pathway of paclitaxel due to its significant impact score.…”
Section: Resultssupporting
confidence: 89%
“…Previous studies of neuropathic pain using lipidomic approach have mainly focused on PG which is rich in fatty acids and strongly contributes to the development of neuropathic pain [4]. Recently, phospholipids such as lysophosphatidylinositol and lysophosphatidylcholine were found to be also modulators of neuropathic pain [35, 36]. …”
Section: Discussionmentioning
confidence: 99%
“…In rats, NOS expression was higher than controls in DRG neurons after axotomy (Fiallos-Estrada et al, 1993;Shi et al, 1998;Verge, Xu, Xu, Wiesenfeld-Hallin, & Hokfelt, 1992) or visceral inflammation (Callsen-Cencic & Mense, 1997). It was proposed that NO can contribute to the excitation of sensory neurons and to pain (Cairns et al, 2014;Steel et al, 1994;Wang, Tsai, Chen, Lin, & Lue, 2013), but the underlying mechanisms have not been clarified. Afferent firing or excitatory transmitters such as calcitonin gene-related peptide (CGRP; Li, Vause, & Durham, 2008) or ATP (Borsani et al, 2010) raise intracellular Ca 2+ ([Ca 2+ ] in ) in sensory neurons, which in turn induces NOS activation and NO production.…”
Section: Introductionmentioning
confidence: 99%